Haemonetics Corporation (FRA:HAZ)

Market Cap	2.41B -29.7%
Revenue (ttm)	1.12B -4.0%
Net Income	149.12M +34.9%
EPS	3.10 +43.8%
Shares Out	n/a
PE Ratio	16.19
Forward PE	11.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	51.00
Previous Close	51.00
Day's Range	51.00 - 51.00
52-Week Range	39.80 - 73.50
Beta	n/a
RSI	42.87
Earnings Date	Feb 5, 2026

About Haemonetics

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools....

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1971
• Employees: 3,023
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HAZ

Financial Performance

In fiscal year 2025, Haemonetics's revenue was $1.36 billion, an increase of 3.95% compared to the previous year's $1.31 billion. Earnings were $167.68 million, an increase of 42.64%.

Financial numbers in USD